These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 15884749

  • 1. Introducing hepatitis B virus vaccine into the Expanded Programme on Immunization in Bangladesh: a proposed method to evaluate whether the existing infrastructure has the capacity.
    Trama A, Walker D, Fox-Rushby J.
    J Health Popul Nutr; 2005 Mar; 23(1):25-33. PubMed ID: 15884749
    [Abstract] [Full Text] [Related]

  • 2. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa.
    Edmunds W, Dejene A, Mekonnen Y, Haile M, Alemnu W, Nokes D.
    Health Policy Plan; 2000 Dec; 15(4):408-16. PubMed ID: 11124244
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake.
    Suckling RM, Taegtmeyer M, Nguku PM, Al-Abri SS, Kibaru J, Chakaya JM, Tukei PM, Gilks CF.
    J Hosp Infect; 2006 Nov; 64(3):271-7. PubMed ID: 16926061
    [Abstract] [Full Text] [Related]

  • 4. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.
    Griffiths UK, Korczak VS, Ayalew D, Yigzaw A.
    Vaccine; 2009 Feb 25; 27(9):1426-32. PubMed ID: 19146901
    [Abstract] [Full Text] [Related]

  • 5. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM, Gleizes O, Covilard JP.
    Vaccine; 2005 Aug 31; 23(37):4610-8. PubMed ID: 15979769
    [Abstract] [Full Text] [Related]

  • 6. The impact of state policies on vaccine coverage by age 13 in an insured population.
    Olshen E, Mahon BE, Wang S, Woods ER.
    J Adolesc Health; 2007 May 31; 40(5):405-11. PubMed ID: 17448397
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Costs of running a universal adolescent hepatitis B vaccination programme.
    Wallace LA, Young D, Brown A, Cameron JC, Ahmed S, Duff R, Carman WF, Kitchin NR, Nguyen-Van-Tam JS, Goldberg DJ.
    Vaccine; 2005 Dec 01; 23(48-49):5624-31. PubMed ID: 16099079
    [Abstract] [Full Text] [Related]

  • 9. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia.
    Levin CE, Nelson CM, Widjaya A, Moniaga V, Anwar C.
    Bull World Health Organ; 2005 Jun 01; 83(6):456-61. PubMed ID: 15976897
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of the efficacy of the national immunization programme for hepatitis B.
    Rubin L, Hefer E, Dubnov Y, Warman S, Rishpon S.
    Public Health; 2007 Jul 01; 121(7):529-33. PubMed ID: 17320126
    [Abstract] [Full Text] [Related]

  • 11. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K, Van Damme P.
    Pediatr Infect Dis J; 2008 Oct 01; 27(10):861-9. PubMed ID: 18776823
    [Abstract] [Full Text] [Related]

  • 12. Is universal better than selective immunization in developing world? Vaccines (HBV).
    Boyles S.
    Hepatitis Wkly; 1998 Oct 19; ():7-8. PubMed ID: 12294767
    [Abstract] [Full Text] [Related]

  • 13. Vaccination coverage survey in Dhaka District.
    Khan MN, Rahman ML, Awal Miah A, Islam MS, Musa SA, Tofail F.
    Bangladesh Med Res Counc Bull; 2005 Aug 19; 31(2):46-53. PubMed ID: 16967809
    [Abstract] [Full Text] [Related]

  • 14. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P, Levine R, Makinen M, Brenzel L, Mitchell V, Milstien JB, Kamara L, Landry S.
    Vaccine; 2008 Dec 02; 26(51):6706-16. PubMed ID: 18952134
    [Abstract] [Full Text] [Related]

  • 15. Vaccinating adolescents in high-risk settings: lessons learned from experiences with hepatitis B vaccine.
    Sneller VP, Fishbein DB, Weinbaum CM, Lombard A, Murray P, McLaurin JA, Friedman L, Working Group on Vaccination of High-Risk Adolescents.
    Pediatrics; 2008 Jan 02; 121 Suppl 1():S55-62. PubMed ID: 18174322
    [Abstract] [Full Text] [Related]

  • 16. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S, Khulan J, Bissett SL, Ferns RB, Nymadawa P, Tedder RS.
    J Med Virol; 2006 Dec 02; 78(12):1554-9. PubMed ID: 17063521
    [Abstract] [Full Text] [Related]

  • 17. Implementing the birth dose of hepatitis B vaccine in rural Indonesia.
    Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ.
    Vaccine; 2007 Aug 10; 25(32):5985-93. PubMed ID: 17604881
    [Abstract] [Full Text] [Related]

  • 18. Using lot quality assurance sampling to improve immunization coverage in Bangladesh.
    Tawfik Y, Hoque S, Siddiqi M.
    Bull World Health Organ; 2001 Aug 10; 79(6):501-5. PubMed ID: 11436470
    [Abstract] [Full Text] [Related]

  • 19. Progress in the control of hepatitis B infection in the Western Pacific Region.
    Clements CJ, Baoping Y, Crouch A, Hipgrave D, Mansoor O, Nelson CB, Treleaven S, van Konkelenberg R, Wiersma S.
    Vaccine; 2006 Mar 15; 24(12):1975-82. PubMed ID: 16361001
    [Abstract] [Full Text] [Related]

  • 20. Power cuts and EPI vaccine storage.
    Senanayake MP, Perera AS, De Silva TU.
    Ceylon Med J; 1997 Jun 15; 42(2):69-71. PubMed ID: 9257464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.